Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery

NCT05730413 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT05730413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05730413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery
Lead sponsor
Cairo University
Phase
Phase 4
Overall status
Unknown status
Start date
August 25, 2021
Completion date
September 30, 2023
Enrollment
122 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery bypass grafting, coronary artery disease, postoperative atrial fibrillation